HER2-low breast cancer is highly unstable during disease evolution and has certain biological characteristics, and breast cancer with HER2-low positivity has certain biological characteristics, which are correlated with positive HR and positive AR. This evidence concerns the gene ERBB2 and breast carcinoma.